predispositions, 2, 3, 6, [17] [18] [19] [20] [21] association with other autoimmune diseases, 18 and a positive response to 8 0 immunosuppression. [20] [21] [22] Two studies have suggested that there are dogs with CH that respond to and renal transplantation. 32 CsA is well tolerated in most dogs. The most common reported board certified internists (DCT, CLW) to ensure adherence to WSAVA (World Small Animal
Veterinary Association) histologic criteria and limit inclusion to dogs with presumed idiopathic 1 1 6
CH. 8 Dogs with exposure to chronic hepatotoxic drugs/supplements or evidence of systemic used for assessment of parametric continuous variables (age, weight, and pre-treatment ALT 1 9 9
[xULN]). Likelihood of remission was also analyzed with a Cox Proportional Hazards Model of 2 0 0 survival analysis. Dogs that did not achieve remission or were lost to follow up were censored in analyze the relationship between each categorical variable and time to remission.
0 3
All statistical analyses were performed by a statistician using a commercial software package. Results:
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The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. . https://doi.org/10.1101/453977 doi: bioRxiv preprint Forty-eight dogs were included in the study of which 26/48 (54%) were female spayed, 20/48 2 0 8 (42%) were male castrated, and 2/48 (4%) were male intact. Median age was 8.5 years (range, 2 0 9 0.7-14 years). Median weight was 19.4 kg (range, 2.2-45kg). Twenty-two different breeds were 2 1 0 represented: mixed breed (12), Labrador retriever (10), standard poodle (4), Brittany spaniel (2),
Maltese (2), golden retriever (1), fox terrier (1), English springer spaniel (1), Scottish terrier (1), Yorkshire terrier (1), Doberman pinscher (1). Biopsies were performed laparoscopically (39/48),
via ultrasound guidance (6/48), and surgically (3/48). amoxicillin/clavulanic acid, metronidazole, and/or enrofloxacin) prior to or shortly after the liver 2 2 5 biopsy was performed. Twelve dogs (25%) were on prednisolone prior to CsA therapy and were 2 2 6 tapered off corticosteroids completely before (2/12) or within 6 months of CsA initiation (10/12).
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Of the 12 dogs, one was on azathioprine concurrently, which was tapered and discontinued Three dogs were on therapy for ascites (spironolactone +/-furosemide). Concurrent diet:
Twenty of 46 dogs (43%) with available diet information were on commercially available Leptospirosis results:
Seventeen of 48 dogs (35%) had leptospirosis microscopic agglutination serology performed of All rights reserved. No reuse allowed without permission.
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The most common adverse effects associated with CsA therapy were gastrointestinal signs in considered a marker of more advanced disease, did not change over time in this study, this may
have been a type II error due to small sample size and the mild degree of hypoalbuminemia.
Hypoalbuminemia was present in only 6 dogs in this study of which only 2 had markedly 3 5 2 decreased albumin levels (1.6 g/dL and 1.8 g/dL). Although not statistically significant, serum The failure of remission in 21% of the dogs in this study could be explained by the individual
variability in the pharmacology and pharmacodynamic response to CsA that is known to exist in Although previous studies suggested that corticosteroids are beneficial in some dogs with makes it easier to use serum liver enzyme activity as a biomarker of response to therapy.
This study also showed that CsA was fairly well tolerated. The most common side effects were dermatitis. [25] [26] [27] [28] Gingival hyperplasia was the second most common side effect observed in our contaminants or opportunistic infections rather than primary pathogens. In future studies, Limitations:
This study had several limitations. were converted to xULN or LLN in an attempt to standardize the data. In humans, the diagnostic criteria for autoimmune hepatitis are clearly established and scored All rights reserved. No reuse allowed without permission.
The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. possible given the retrospective nature of the study that some cases were not truly idiopathic CH.
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Remission criteria are also standardized in humans and include normalization of serum ALT, resolution of CH (based on examination of repeat liver biopsies).
3
Since this was a retrospective study, treatment and monitoring protocols were not standardized. had unknown outcome data and only nineteen dogs had available serum ALP and ALT data > 2 4 5 0 years after baseline. Due to this lack of follow-up, survival analysis could not be performed. All rights reserved. No reuse allowed without permission.
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Conclusion:
4 5 5
In conclusion, this study demonstrated that CsA is a well-tolerated and potentially effective 4 5 6 medication in normalizing serum liver enzymes and total bilirubin in dogs with idiopathic CH.
5 7
Previously reported poor prognostic factors in CH did not affect the ability of CsA to induce 4 5 8 remission. These findings provide further evidence that in some dogs, CH is immune-mediated.
5 9
Further prospective studies will be necessary to determine whether CsA therapy results in All rights reserved. No reuse allowed without permission.
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